Copertina

Primary retroperitoneal lymph node dissection for clinical stage II seminoma: Comparative analysis against established paradigms using the National Cancer Data Base

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Josiah K. Low, John E. Musser
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	BJUI Compass
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Prevention of lymphoceles using peritoneal flaps during robotic‐assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta‐analysis
di: Huseyin Yildiz, et al.
Pubblicazione: (2026)

Post‐operative incidence of lymphedema after RARP with or without extended pelvic lymph node dissection in a cohort study
di: Andries Clinckaert, et al.
Pubblicazione: (2024)

Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy
di: Georgios Daouacher, et al.
Pubblicazione: (2026)

Modified technique for dissection of working space in retroperitoneal laparoscopic surgery: A step‐by‐step guide
di: Xiaofeng Xu, et al.
Pubblicazione: (2025)

Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
di: Sean Lim, et al.
Pubblicazione: (2026)

Robotic retroperitoneal surgery in a uro‐oncology specialised centre: Translating RPLND expertise from testicular cancer to non‐genitourinary retroperitoneal tumour resection
di: Alberto Costa Silva, et al.
Pubblicazione: (2026)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
di: Mohammed Al‐Zubaidi, et al.
Pubblicazione: (2024)

A review of the current treatment methods for retroperitoneal fibrosis with obstructive uropathy
di: Charles Carey, et al.
Pubblicazione: (2024)

Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re‐staging TURBT and Intravesical Adjuvant Therapy
di: Tarek Ajami, et al.
Pubblicazione: (2024)

Single‐port robot‐assisted ureterolysis for retroperitoneal fibrosis: A less invasive path to functional recovery
di: Filippo Carletti, et al.
Pubblicazione: (2026)

Lymph node surgery after centralization of penile cancer care in Sweden: Extent of use and complications
di: Åsa Warnolf, et al.
Pubblicazione: (2026)

Giant testicular germ‐cell tumours—An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature
di: Markus Angerer, et al.
Pubblicazione: (2026)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
di: Thomas Philip Cahill, et al.
Pubblicazione: (2024)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
di: Samantha Shekar, et al.
Pubblicazione: (2025)

Therapy de‐escalation for testicular cancer (THERATEST): A multi‐centre observational cohort feasibility study of de‐escalation therapies for good prognosis stage II germ cell tumours
di: Nasreen Abdul Aziz, et al.
Pubblicazione: (2025)

Testosterone nadir and clinical outcomes in patients with advanced prostate cancer: Post hoc analysis of triptorelin pamoate Phase III studies
di: Laurence Klotz, et al.
Pubblicazione: (2024)

Improving clinical efficiency using retrieval‐augmented generation in urologic oncology: A guideline‐enhanced artificial intelligence approach
di: Harry Collin, et al.
Pubblicazione: (2024)

Correction to “Therapy de‐escalation for testicular cancer (THERATEST): A multi‐centre observational cohort feasibility study of de‐escalation therapies for good prognosis stage II germ cell tumours”
Pubblicazione: (2025)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
di: Hugo Klempfner, et al.
Pubblicazione: (2024)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
di: Yin Zhou, et al.
Pubblicazione: (2024)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
di: Ansh Bhatia, et al.
Pubblicazione: (2024)

Early oncological outcomes of delayed radical prostatectomy: A prospective, international, follow‐up analysis of the COVIDSurg‐Cancer study
di: Arjun Nathan, et al.
Pubblicazione: (2024)

Penile cancer in French Guiana: Epidemiology, histopathology and clinical aspects
di: Khalil Chalhoub, et al.
Pubblicazione: (2025)

Early clinical experience with the Carina robotic platform in urologic surgery
di: Hongkai Wang, et al.
Pubblicazione: (2025)

Waiting time in diagnosis and extirpative surgery and association with survival and stage progression in upper tract urothelial carcinomas
di: Fredrik Liedberg, et al.
Pubblicazione: (2025)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
di: Mohamad Baker Berjaoui, et al.
Pubblicazione: (2024)

Scottish National Complex Renal Cyst Surveillance Protocol
di: Benjamin Parkin, et al.
Pubblicazione: (2025)

Safety of urethral preservation using urethral frozen section analysis in radical cystectomy
di: Yuto Hattori, et al.
Pubblicazione: (2024)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
di: Eric V. Li, et al.
Pubblicazione: (2024)

Comparative analysis of early outcomes of the first 150 cases of posterior approach robotic‐assisted radical prostatectomy and identification of the learning curve: A single‐surgeon series
di: Li June Tay, et al.
Pubblicazione: (2025)

Incidental crossed fused renal ectopia detected during prostate cancer staging: A photorealistic three‐dimensional rendering
di: Kei Ushijima, et al.
Pubblicazione: (2025)

Impact of position of bolster on outcome of prone PCNL—A randomized clinical trial
di: Vikram Singh, et al.
Pubblicazione: (2024)

Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
di: Joshua Yi Min Tung, et al.
Pubblicazione: (2026)

Ureteral stent symptoms: A systematic review and meta‐analysis comparing the use of mirabegron and tamsulosin
di: Daniel Madarshahian, et al.
Pubblicazione: (2025)

National survey of urologists' views on prostate cancer screening in the United Kingdom
di: Nikhil Mayor, et al.
Pubblicazione: (2026)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
di: Muhammad Imran, et al.
Pubblicazione: (2026)

MRI performance to identify clinically significant prostate cancer following focal cryo‐ablation
di: Herbert Lepor, et al.
Pubblicazione: (2025)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
di: Rodolfo Hurle, et al.
Pubblicazione: (2025)

Omission of contralateral biopsies in unilateral MRI‐suspicious prostate cancer has minimal impact on clinical risk assessment
di: Stijn M. van den Bosch, et al.
Pubblicazione: (2026)

Multiparametric‐magnetic resonance imaging (mp‐MRI) of the prostate and Urolift: Identifying artefact size, location and clinical implications
di: Cameron James Parkin, et al.
Pubblicazione: (2024)